satranidazole has been researched along with Amebiasis, Intestinal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhopale, KK; Chatterjee, DK; Dutta, AK; Nagarajan, K; Ray, DK; Shrivastava, VB; Tendulkar, JS | 1 |
| Mankodi, NA; Paul, T; Ray, DK; Sheth, UK; Vaidya, AB | 1 |
| Nagarajan, K; Ray, DK; Shrivastava, VB; Tendulkar, JS | 1 |
3 other study(ies) available for satranidazole and Amebiasis, Intestinal
| Article | Year |
|---|---|
Comparative studies on the amoebicidal activity of known 5-nitroimidazole derivatives and CG 10213-Go in golden hamsters, Mesocricetus auratus, infected in the liver or caecum or both with trophozoites of Entamoeba histolytica.
Topics: Amebicides; Animals; Cecal Diseases; Cricetinae; Dysentery, Amebic; Entamoeba histolytica; Female; Liver Abscess, Amebic; Male; Mesocricetus; Metronidazole; Nitroimidazoles | 1983 |
Phase 1 tolerability and antiamoebic activity studies with 1-methylsulphonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone (Go.10213): a new antiprotozoal agent.
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Drug Evaluation; Dysentery, Amebic; Humans; Male; Middle Aged; Nitroimidazoles | 1983 |
Comparative efficacy of metronidazole and another 5-nitroimidazole, CG-10213-Go, in caecal amoebiasis in albino mice (Mus musculus).
Topics: Amebicides; Animals; Cecal Diseases; Dysentery, Amebic; Metronidazole; Mice; Nitroimidazoles | 1982 |